COPD Personalization: Boehringer Ingelheim's Digital Tool
Agency
Brand
Platforms
None
Services
Industries
Boehringer Ingelheim partnered with Dawn Technology to develop a digital tool that empowers COPD patients to take control of their health through personalized monitoring. The platform enables patients to track symptoms, share insights with healthcare providers, and receive tailored care recommendations. By leveraging AI-driven analytics, the solution enhances patient engagement and improves the quality of care. The initiative resulted in a 30% increase in self-management adherence among participants. The project demonstrated the potential of technology to transform how chronic disease management is approached, offering a scalable model for personalized healthcare delivery.
View the full case on the agency site
Original write-up, full visuals, full context.
Published around:
January 6, 2026
?
Added to Agency Inside:
March 22, 2026